It is tempting to postulate that an increased cytoplasmic Ca2+ signal might possibly be used as a surrogate marker for the identification of RA patients in whom combination of MTX with leflunomide will not be sufficient and leflunomide is recommended to be replaced by an anti-TNF agent. Here, TNF is linked to rheumatoid arthritis.